Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression
Purpose
The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.
Condition
- Postpartum Depression (PPD)
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- ≤ 6 months postpartum 2. EPDS score >10
Exclusion Criteria
- Current or past-year substance use disorder 2. Lifetime history of bipolar disorder or psychotic disorder 3. Active suicidal intent 4. Retinal pathology or history of eye surgery 5. Current use of photosensitizing medications 6. Untreated sleep-disordered breathing, untreated restless legs syndrome, or narcolepsy 7. Psychotherapy or psychotropic medications started/dose changed in past month (psychotherapy started and/or current medication at stable dose ≥ 4 weeks are permitted) 8. Medical conditions contraindicated for mBLT (e.g., epilepsy/seizures)
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- N/A
- Intervention Model
- Single Group Assignment
- Primary Purpose
- Other
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Light therapy |
Participants in the arm will be approximately 30 women who are within 6 months postpartum and have an Edinburgh Postnatal Depression Scale (EPDS) score > 10. |
|
Recruiting Locations
More Details
- Status
- Recruiting
- Sponsor
- University of Michigan
Detailed Description
This study will test a consumer health light therapy device (Re-Timer)
